Works matching AU Heerspink, Hiddo J. L.

Results: 176
    1

    Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.

    Published in:
    Cardiovascular Drugs & Therapy, 2020, v. 34, n. 3, p. 311, doi. 10.1007/s10557-020-06954-6
    By:
    • Yurista, Salva R.;
    • Silljé, Herman H. W.;
    • van Goor, Harry;
    • Hillebrands, Jan-Luuk;
    • Heerspink, Hiddo J. L.;
    • de Menezes Montenegro, Luiz;
    • Oberdorf-Maass, Silke U.;
    • de Boer, Rudolf A.;
    • Westenbrink, B. Daan
    Publication type:
    Article
    2

    [18F]FDG Uptake in Adipose Tissue Is Not Related to Inflammation in Type 2 Diabetes Mellitus.

    Published in:
    Molecular Imaging & Biology, 2021, v. 23, n. 1, p. 117, doi. 10.1007/s11307-020-01538-0
    By:
    • Reijrink, Melanie;
    • de Boer, Stefanie A.;
    • Antunes, Ines F.;
    • Spoor, Daan S.;
    • Heerspink, Hiddo J. L.;
    • Lodewijk, Monique E.;
    • Mastik, Mirjam F.;
    • Boellaard, Ronald;
    • Greuter, Marcel J. W.;
    • Benjamens, Stan;
    • Borra, Ronald J. H.;
    • Slart, Riemer H. J. A.;
    • Hillebrands, Jan-Luuk;
    • Mulder, Douwe J.
    Publication type:
    Article
    3
    4

    Methods and rationale of the DISCOVER CKD global observational study.

    Published in:
    Clinical Kidney Journal, 2021, v. 14, n. 6, p. 1570, doi. 10.1093/ckj/sfab046
    By:
    • Pecoits-Filho, Roberto;
    • James, Glen;
    • Carrero, Juan Jesus;
    • Wittbrodt, Eric;
    • Fishbane, Steven;
    • Sultan, Alyshah Abdul;
    • Heerspink, Hiddo J L;
    • Hedman, Katarina;
    • Kanda, Eiichiro;
    • Chen, Hungta (Tony);
    • Kashihara, Naoki;
    • Sloand, James;
    • Kosiborod, Mikhail;
    • Kumar, Supriya;
    • Lainscak, Mitja;
    • Arnold, Matthew;
    • Lam, Carolyn S P;
    • Holmqvist, Björn;
    • Pollock, Carol;
    • Fenici, Peter
    Publication type:
    Article
    5
    6
    7

    CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.

    Published in:
    Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02180-8
    By:
    • Schnell, Oliver;
    • Barnard-Kelly, Katharine;
    • Battelino, Tadej;
    • Ceriello, Antonio;
    • Larsson, Helena Elding;
    • Fernández-Fernández, Beatriz;
    • Forst, Thomas;
    • Frias, Juan-Pablo;
    • Gavin III, James R.;
    • Giorgino, Francesco;
    • Groop, Per-Henrik;
    • Heerspink, Hiddo J. L.;
    • Herzig, Stephan;
    • Hummel, Michael;
    • Huntley, George;
    • Ibrahim, Mahmoud;
    • Itzhak, Baruch;
    • Jacob, Stephan;
    • Ji, Linong;
    • Kosiborod, Mikhail
    Publication type:
    Article
    8
    9
    10

    Canagliflozin and iron metabolism in the CREDENCE trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 696, doi. 10.1093/ndt/gfae198
    By:
    • Koshino, Akihiko;
    • Heerspink, Hiddo J L;
    • Jongs, Niels;
    • Badve, Sunil V;
    • Arnott, Clare;
    • Neal, Bruce;
    • Jardine, Meg;
    • Mahaffey, Kenneth W;
    • Pollock, Carol;
    • Perkovic, Vlado;
    • Hansen, Michael K;
    • Bakker, Stephan J L;
    • Wada, Takashi;
    • Neuen, Brendon L
    Publication type:
    Article
    11

    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 4, p. 679, doi. 10.1093/ndt/gfae180
    By:
    • Gross, Oliver;
    • Boeckhaus, Jan;
    • Weber, Lutz T;
    • Heerspink, Hiddo J L;
    • Simon, James F;
    • Ahmed, Rees;
    • Gerst, Christoph;
    • Duerr, Ulrike;
    • Walker, Florian;
    • Tostmann, Ralf;
    • Helm, Jürgen;
    • Asendorf, Thomas;
    • Friede, Tim;
    • Nephrology, for the study group of the German Society of Pediatric
    Publication type:
    Article
    12
    13

    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.

    Published in:
    Nephrology Dialysis Transplantation, 2025, v. 40, n. 2, p. 308, doi. 10.1093/ndt/gfae132
    By:
    • Heerspink, Hiddo J L;
    • Agarwal, Rajiv;
    • Bakris, George L;
    • Cherney, David Z I;
    • Lam, Carolyn S P;
    • Neuen, Brendon L;
    • Sarafidis, Pantelis A;
    • Tuttle, Katherine R;
    • Wanner, Christoph;
    • Brinker, Meike D;
    • Dizayee, Sara;
    • Kolkhof, Peter;
    • Schloemer, Patrick;
    • Vesterinen, Paula;
    • Perkovic, Vlado;
    • investigators, for the FIND-CKD
    Publication type:
    Article
    14
    15
    16
    17

    Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

    Published in:
    Nephrology Dialysis Transplantation, 2024, v. 39, n. 3, p. 414, doi. 10.1093/ndt/gfad183
    By:
    • Heerspink, Hiddo J L;
    • Greasley, Peter J;
    • Ahlström, Christine;
    • Althage, Magnus;
    • Dwyer, Jamie P;
    • Law, Gordon;
    • Wijkmark, Emma;
    • Lin, Min;
    • Mercier, Anne-Kristina;
    • Sunnåker, Mikael;
    • Turton, Michelle;
    • Wheeler, David C;
    • Ambery, Philip
    Publication type:
    Article
    18
    19

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1260, doi. 10.1093/ndt/gfac280
    By:
    • McEwan, Phil;
    • Boyce, Rebecca;
    • Sanchez, Juan Jose Garcia;
    • Sjöström, C David;
    • Stefansson, Bergur;
    • Nolan, Stephen;
    • Correa-Rotter, Ricardo;
    • Rossing, Peter;
    • Chertow, Glenn M;
    • McMurray, John J V;
    • Wheeler, David C;
    • Heerspink, Hiddo J L
    Publication type:
    Article
    20
    21

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.

    Published in:
    Nephrology Dialysis Transplantation, 2022, v. 37, n. 9, p. 1647, doi. 10.1093/ndt/gfab335
    By:
    • Wheeler, David C;
    • Jongs, Niels;
    • Stefansson, Bergur V;
    • Chertow, Glenn M;
    • Greene, Tom;
    • Hou, Fan Fan;
    • Langkilde, Anna Maria;
    • McMurray, John J V;
    • Rossing, Peter;
    • Nowicki, Michal;
    • Wittmann, István;
    • Correa-Rotter, Ricardo;
    • Sjöström, C David;
    • Toto, Robert D;
    • Heerspink, Hiddo J L;
    • Investigators, DAPA-CKD Trial Committees and
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 2, p. 274, doi. 10.1093/ndt/gfz290
    By:
    • Heerspink, Hiddo J L;
    • Stefansson, Bergur V;
    • Chertow, Glenn M;
    • Correa-Rotter, Ricardo;
    • Greene, Tom;
    • Hou, Fan-Fan;
    • Lindberg, Magnus;
    • McMurray, John;
    • Rossing, Peter;
    • Toto, Roberto;
    • Langkilde, Anna Maria;
    • Wheeler, David C;
    • Investigators, for the DAPA-CKD
    Publication type:
    Article
    29
    30

    Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 1, p. 138, doi. 10.1093/ndt/gfy217
    By:
    • Provenzano, Michele;
    • Chiodini, Paolo;
    • Minutolo, Roberto;
    • Zoccali, Carmine;
    • Bellizzi, Vincenzo;
    • Conte, Giuseppe;
    • Locatelli, Francesco;
    • Tripepi, Giovanni;
    • Vecchio, Lucia Del;
    • Mallamaci, Francesca;
    • Micco, Lucia Di;
    • Russo, Domenico;
    • Heerspink, Hiddo J L;
    • Nicola, Luca De
    Publication type:
    Article
    31
    32
    33
    34
    35

    Erratum.

    Published in:
    2018
    By:
    • Dekkers, Claire C J;
    • Wheeler, David C;
    • Sjöström, C David;
    • Stefansson, Bergur V;
    • Cain, Valerie;
    • Heerspink, Hiddo J L
    Publication type:
    Correction Notice
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50